Walgreens expands coronavirus drive-through testing, triples capacity

By LabPulse.com staff writers

April 27, 2020 -- Working in partnership with LabCorp, Walgreens is planning a dramatic expansion of its drive-through testing services across the U.S., with the goal of tripling capacity.

The pharmacy chain will offer LabCorp's diagnostic nasal swab test in 49 U.S. states and Puerto Rico and plans to have the capacity to test 50,000 people per week. The swab specimen is taken by patients themselves with the oversight of pharmacists. Walgreens currently has 18 COVID-19 drive-through testing locations in 11 states.

"The scale and timing of the overall testing expansion is dependent on the availability of tests and overall lab capacity," Walgreens said in a statement.

LabCorp's antibody test for the novel coronavirus is available at 100 Walgreens locations.

CVS Health paves way for genetic testing of cancer patients
CVS Health is launching a program that will facilitate genetic testing for cancer patients at the point of prescribing to guide personalized treatment...
LabCorp joins forces with Ind. nonprofit
LabCorp has acquired the diagnostic clinical laboratory assets of the Indiana-based nonprofit South Bend Medical Foundation (SBMF) and will be providing...
LabCorp builds on consumer tests
LabCorp is now offering consumers the ability to buy tests online, get tested by a phlebotomist at a convenient location, and receive results through...

Copyright © 2020 LabPulse.com

Last Updated ls 4/27/2020 2:46:12 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current